Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry

Medicine & Life Sciences

• American Heart Association 100%
• Troponin 99%
• Risk Assessment 83%
• Registries 79%
• fibrin fragment D 79%
• Cardiovascular Diseases 72%
• Biomarkers 65%
• Ferritins 35%
• C-Reactive Protein 29%
• Severe Acute Respiratory Syndrome 21%
• Coronavirus 21%
• Natriuretic Peptides 20%
• Hospital Mortality 16%
• Thrombosis 12%
• Logistic Models 10%
• Odds Ratio 10%
• Inflammation 9%
• Wounds and Injuries 8%